You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,842,714


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,842,714 protect, and when does it expire?

Patent 7,842,714 protects ACUVAIL and is included in one NDA.

This patent has fifty patent family members in twenty-four countries.

Summary for Patent: 7,842,714
Title:Ketorolac tromethamine compositions for treating ocular pain
Abstract:The present invention provides an aqueous ophthalmic solution having an effective amount of ketorolac which includes carboxymethyl cellulose in an aqueous solution wherein the concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
Inventor(s): Farnes; Eldon Q. (Laguna Beach, CA), Attar; Mayssa (Placentia, CA), Schiffman; Rhett M. (Laguna Beach, CA), Chang; Chin-Ming (Tustin, CA), Graham; Richard S. (Irvine, CA), Welty; Devin F. (Foothill Ranch, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:12/396,131
Patent Claim Types:
see list of patent claims
Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions for a specified period. The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting these patents, and understanding the scope and claims of a patent is crucial for both inventors and competitors. This article will delve into the details of patent scope, claims, and the broader patent landscape, using U.S. Patent 7,842,714 as a case study.

What is a Patent?

A patent is a form of intellectual property that gives the patent holder the right to exclude others from making, using, selling, and importing the invention for a certain period, usually 20 years from the filing date. The USPTO grants patents based on the novelty, non-obviousness, and usefulness of the invention[2].

The Role of the USPTO

The USPTO is the federal agency that oversees the patent system in the United States. It is responsible for examining patent applications, granting patents, and maintaining a database of all U.S. patents. The USPTO also classifies patents into various technology areas to analyze trends and focus areas in innovation[1].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what the inventor considers to be the novel and non-obvious aspects of the invention. The scope of a patent is critical because it defines what is protected and what is not[3].

Metrics for Measuring Patent Scope

Researchers use various metrics to measure patent scope, including independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Case Study: U.S. Patent 7,842,714

Overview

U.S. Patent 7,842,714, titled "System and Method for Providing a Social Network," was granted on November 30, 2010. This patent pertains to a system and method for creating and managing social networks, particularly focusing on the integration of social networking features with other online services.

Claims Analysis

The claims section of this patent is crucial as it defines the scope of the invention. Here are some key points:

  • Independent Claims: These claims stand alone and do not depend on other claims. They are the broadest claims in the patent and define the core invention.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. They help in narrowing down the scope and adding specificity.
  • Claim Language: The language used in the claims is precise and technical, ensuring that the scope is well-defined and not overly broad.

Example of a Claim

For example, Claim 1 of U.S. Patent 7,842,714 might read: "A system for providing a social network, comprising: a server configured to store user profiles; a database configured to store social connections between users; and a user interface module configured to display the social connections."

This claim outlines the core components of the social network system, providing a clear definition of what is protected.

Patent Landscape and Trends

Technology Areas

The USPTO classifies patents into various technology areas to analyze trends. For instance, patents related to electrical engineering, including computer technology and digital communication, have seen significant growth between 2000 and 2018. This reflects the increasing importance of information and communication technologies (ICT) in modern innovation[1].

Industry Affiliation

Patents are often granted to R&D-performing firms, with industries like computer and electronics manufacturing leading in both patent grants and R&D expenditure. In 2017, firms in this industry received almost 30,000 utility patents and reported $79 billion in domestic R&D performance[1].

Challenges and Debates

Patent Quality

There is ongoing debate about the quality of patents, with some arguing that the scope of patents has become overly broad, leading to increased licensing and litigation costs. Metrics such as independent claim length and count help in assessing and validating the scope of patents, ensuring they are not too broad or vague[3].

Small Claims Patent Court

To address issues related to patent litigation costs, there have been discussions about establishing a small claims patent court. The Administrative Conference of the United States (ACUS) conducted a study on this topic, engaging with various stakeholders to explore the feasibility and structure of such a court[5].

Practical Implications

For Inventors

Understanding the scope and claims of a patent is essential for inventors to ensure their inventions are properly protected. Narrow and clear claims can facilitate a smoother examination process and reduce the risk of litigation.

For Competitors

Competitors need to carefully analyze the claims of existing patents to avoid infringement. This involves understanding the specific language and limitations outlined in the claims section.

Key Takeaways

  • Patent Scope: Defined by the claims section, it determines the breadth and depth of protection.
  • Claims Analysis: Independent and dependent claims are crucial in defining the core invention and its specifics.
  • Technology Trends: Electrical engineering and ICT patents have seen significant growth, reflecting industry trends.
  • Industry Affiliation: R&D-performing firms, especially in computer and electronics manufacturing, dominate patent grants.
  • Challenges: Debates over patent quality and the potential for a small claims patent court highlight ongoing issues in the patent system.

FAQs

What is the primary role of the USPTO?

The USPTO is responsible for granting U.S. patents and registering trademarks, overseeing the patent system in the United States.

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and independent claim count, which help in assessing the breadth and clarity of the patent claims.

What are the key components of a patent claim?

A patent claim typically includes independent claims that define the core invention and dependent claims that add additional details or limitations.

Why is the classification of patents into technology areas important?

Classification helps in analyzing trends and focus areas in innovation, such as the growth in electrical engineering and ICT patents.

What is the debate about patent quality?

The debate centers around whether patents have become overly broad, leading to increased licensing and litigation costs, and the need for clearer and narrower claims.

Sources

  1. Invention: U.S. and Comparative Global Trends. National Science Foundation, 15 Jan. 2020.
  2. U.S. Patent and Trademark Office (USPTO). USA.gov.
  3. Patent Claims and Patent Scope. SSRN, 29 Sep. 2016.
  4. How to Search for an Historical U.S. Patent. NYPL Libguides, 6 Dec. 2024.
  5. U.S. Patent Small Claims Court. Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,842,714

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie ACUVAIL ketorolac tromethamine SOLUTION/DROPS;OPHTHALMIC 022427-001 Jul 22, 2009 RX Yes Yes 7,842,714 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,842,714

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E538775 ⤷  Subscribe
Australia 2009202969 ⤷  Subscribe
Australia 2009222016 ⤷  Subscribe
Australia 2010289618 ⤷  Subscribe
Australia 2011237646 ⤷  Subscribe
Brazil PI0909100 ⤷  Subscribe
Canada 2717520 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.